Daniel Abdun-Nabi
SVP Corp Aff, GC & Secretary, Emergent BioSolutions.
Companies
- Aptevo Therapeutics Inc.Board member Aug 2, 2016 to now1
- REGENXBIO Inc.Board member Aug 9, 2016 to Jun 8, 20212
- Emergent BioSolutionsChief executive officer Dec 28, 2012 to Mar 4, 20193
- Emergent BioSolutionsBoard member Aug 13, 2009 to Mar 4, 20194
- Emergent BioSolutionsPresident Apr 3, 2007 to Mar 13, 20185
- Emergent BioSolutionsChief operating officer May 31, 2007 to Mar 16, 20126
- Emergent BioSolutionsSVP Corp Aff, GC & Secretary Nov 14, 2006 to Dec 15, 20067
Holdings
Stock this person has reported owning, from the forms officers and directors file with the SEC. See the biggest insider stakes.
Shares held
- Aptevo Therapeutics Inc. APVO400 shares8$648 at $1.62Aug 6, 2026
As of each latest filing. The line shows shares held over time.
Recent filings
- Aug 6, 2026Exercised options 400 shares of Aptevo Therapeutics Inc.8
- Jul 17, 2025Exercised options 1 shares of Aptevo Therapeutics Inc.9
- Jun 2, 2024Exercised options 81 shares of Aptevo Therapeutics Inc.10
- Jun 1, 2024Exercised options 7 shares of Aptevo Therapeutics Inc.10
- Aug 9, 2023Exercised options 3,571 shares of Aptevo Therapeutics Inc.11
- Jun 1, 2023Exercised options 297 shares of Aptevo Therapeutics Inc.12
- Jun 1, 2022Exercised options 298 shares of Aptevo Therapeutics Inc.13
Sources
The numbers on this page point here. Each one links to the record it came from.
- 1
- 2SEC EDGARREGENXBIO Inc., Board member
- 3
- 4SEC EDGAREmergent BioSolutions, Board member
- 5SEC EDGAREmergent BioSolutions, President
- 6
- 7
- 8
- 9SEC EDGARForm 4 filed Jul 21, 2025
- 10SEC EDGARForm 4 filed Jun 3, 2024
- 11SEC EDGARForm 4 filed Aug 10, 2023
- 12SEC EDGARForm 4 filed Jun 2, 2023
- 13SEC EDGARForm 4 filed Jun 3, 2022